Major stock indexes ended mostly higher Wednesday, building on a long run of gains. The S&P…
Tag: Biogen
A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs to expand imaging market for companies in diagnostics sector.
Biogen to Cut Roughly 11% of Workforce to Focus on Big-Return Drugs
The biotech company cited the launch of Alzheimer’s drug Lekembi as part of its new focus…
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
The agency’s full approval may result in people enrolled in Medicare receiving anti-amyloid treatment.
Alzheimer’s Blockbuster Is Coming, but Slowly
The developers of Alzheimer’s drugs have worked hard to make treatment available to patients.
Alzheimer’s Blockbuster Is Coming, but Slowly
The developers of Alzheimer’s drugs have worked hard to make treatment available to patients.
Medicare Plans to Cover Alzheimer’s Drugs
Biogen and Eisai’s Leqembi is slated for full approval this summer.
Biogen Boss Turns Corner on Alzheimer’s Miscues
The biotech company needs to embark on a new growth path as former Sanofi CEO Chris…
FDA Rejects Lilly’s Alzheimer’s Drug Candidate, Seeks More Data
Business Health care Health The setback could delay the potential commercial introduction of a drug called…